US | pharmaphorum

US

News

Building site with thre emen in high viz jackets and protective headweare

AZ builds in China, as J&J ramps up its US investments

AstraZeneca will open its sixth R&D centre in China, while J&J announces four new manufacturing facilities in the US in a major reshoring drive.

News

President Donald Trump's new official portrait

Experts deplore Trump's order for US to exit from WHO

One of the first acts of President Donald Trump after his inauguration yesterday was to order the start of the US's withdrawal from the WHO.

News

Chasing $80bn sales target, AZ unveils $3.5bn US investment

AstraZeneca plans to invest a whopping $3.5 billion to expand its R&D and manufacturing operations in the US by 2026, as part of a drive to raise its revenues to $80 billion by the end

News

GSK plans $800m US manufacturing investment

GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US.

News

US Congress passes bill to end Parkinson’s disease

The US Senate has joined the House of Representatives in approving the first-ever federal bill dedicated to ending Parkinson’s disease, modelled on similar legislation for

News

Next stage in GSK’s Zantac defense gets underway today

A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients.

AZ builds in China, as J&J ramps up its US investments

Experts deplore Trump's order for US to exit from WHO

Chasing $80bn sales target, AZ unveils $3.5bn US investment

GSK plans $800m US manufacturing investment

US Congress passes bill to end Parkinson’s disease

Next stage in GSK’s Zantac defense gets underway today

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

US

Editor's Picks